Ttc7b is a novel prognostic-related biomarker in glioma correlating with immune infiltrates and response to oxidative stress by temozolomide

HIGHLIGHTS

  • who: Zhenhua Chen et al. from the Department of Neurosurgery, Affiliated Hospital , of Nantong University and First People`s Hospital of Nantong City, North Haierxiang Road, #, Nantong, China have published the paper: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide, in the Journal: Oxidative Medicine and Cellular Longevity of 20/09/2022
  • what: The local recurrence of tumor is closely associated with tumor heterogeneity, and the immune microenvironment of malignant tumor is a major reason for the failure of the treatment of malignant . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?